DJIA 17,083.80 -2.83 -0.02%
NASDAQ 4,472.11 -1.59 -0.04%
S&P 500 1,987.98 0.97 0.05%
market minute promo

3.39 -0.06 (-1.74%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

RIGL $3.39 -1.74%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.46
Previous Close $3.45
Daily Range $3.36 - $3.53
52-Week Range $2.31 - $5.00
Market Cap $296.7M
P/E Ratio -3.52
Dividend (Yield) $0.00 (0.0%)
Volume 402,276
Average Daily Volume 454,695
Current FY EPS -$1.04

Sector

Healthcare

Industry

Drugs

Rigel Pharmaceuticals, Inc. (RIGL) Description

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Website: http://www.rigel.com/

News & Commentary

Rigel Pharmaceuticals Starts Fostamatinib Late Stage Program - Analyst Blog

Rigel Initiates Phase 3 Studies Of Fostamatinib In ITP

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape

Is Rigel Pharmaceuticals (RIGL) Stock a Solid Choice Right Now? - Tale of the Tape

Rigel (RIGL) Worth Watching: Stock Rises 10.2% - Tale of the Tape

Rigel Rises on Narrower Q4 Loss - Analyst Blog

Benzinga's Top #PreMarket Gainers

Rigel Narrows Loss, Shares Continue to Fall - Analyst Blog

First Week Of November 16th Options Trading For Rigel Pharmaceuticals (RIGL)

1 Big Pharma Leaps Past Hurdle

Sanofi won EU approval for MS drug Lemtrada this week.

The Rise of Little Pharma

Why focusing on Little Pharma could lead to big gains.

See More RIGL News...

RIGL's Top Competitors

RIGL $3.39 (-1.74%)
Current stock: RIGL
BIIB $336.79 (-0.24%)
Current stock: BIIB
AMGN $122.26 (0.20%)
Current stock: AMGN
CELG $86.19 (-3.29%)
Current stock: CELG